In preclinical study of breast cancer, heparin binding EGF, ligand of EGFR, can enhance the adhesion between tumor cells and brain endothelial cells, and help tumor cells penetrate the blood-brain barrier in breast cancer (92). The gene discussed is EGFR; the disease is neoplasm.